NEW YORK, July 11 - Paradigm Genetics announced yesterday that it had revised its earnings projections for the fourth quarter of 2003 from $.05 to $.06 per share profit to between a loss of $.04 per share and a profit of $.01 cent per share. The original guidance was issued in a year-end conference call held in February.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.